{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:30:17Z","timestamp":1770291017693,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007757","name":"Agencia Canaria de Investigaci\u00f3n, Innovaci\u00f3n y Sociedad de la Informaci\u00f3n","doi-asserted-by":"publisher","award":["TESIS2020010117"],"award-info":[{"award-number":["TESIS2020010117"]}],"id":[{"id":"10.13039\/501100007757","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijpddr.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T11:47:02Z","timestamp":1615117622000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["In vitro validation of the amoebicidal activity of commercial eye drops as second activity"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-3831","authenticated-orcid":false,"given":"Olfa","family":"Chiboub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eulalia","family":"Capote-Yanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Sifaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Reyes -Batlle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n L.","family":"Rodr\u00edguez - Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 E.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Lorenzo-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.02.007_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: characterisation and research methods","author":"Baranowski","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clae.2011.02.003","article-title":"In vitro effects of medium tonicity, nutrient concentration, and free chlorine content on Acanthamoeba","volume":"34","author":"Bergmanson","year":"2011","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48261-7","article-title":"Staurosporine from streptomyces sanyensis activates programmed cell death in Acanthamoeba via the mitochondrial pathway and presents low in vitro cytotoxicity levels in a macrophage cell line","volume":"9","author":"Cartuche","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2009.06.009","article-title":"Acanthamoeba keratitis: diagnosis and treatment update 2009","volume":"148","author":"Dart","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0020-7519(03)00008-0","article-title":"Programmed cell death in trypanosomatids and other unicellular organisms","volume":"33","author":"Debrabant","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9050405","article-title":"Drug discovery against Acanthamoeba infections: present knowledge and unmet needs","volume":"9","author":"Elsheikha","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000334270","article-title":"Double-biguanide therapy for resistant Acanthamoeba keratitis","volume":"2","author":"Ferrari","year":"2011","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib8","doi-asserted-by":"crossref","first-page":"10 pages","DOI":"10.1155\/2014\/256310","article-title":"Morphological features and in vitro cytopathic effect of Acanthamoeba griffini trophozoites isolated from a clinical case","volume":"2014","author":"Gonz\u00e1lez-Robles","year":"2014","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/1440-1681.13335","article-title":"Tobramycin suppresses HUWE1 degradation to control MCL-1 stability during tumour development","volume":"47","author":"He","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-4-44","article-title":"Evolution of apoptosis-like programmed cell death in unicellular protozoan parasites","volume":"4","author":"Kaczanowski","year":"2011","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1574-6976.2006.00023.x","article-title":"Acanthamoeba: biology and increasing importance in human health","volume":"30","author":"Khan","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00436-018-6192-0","article-title":"G418 induces programmed cell death in Acanthamoeba through the elevation of intracellular calcium and cytochrome c translocation","volume":"118","author":"Koutsogiannis","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micpath.2016.12.013","article-title":"Pathogenesis of microbial keratitis","volume":"104","author":"Lakhundi","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/parasite\/2015010","article-title":"An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment","volume":"22","author":"Lorenzo-Morales","year":"2015","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pt.2013.01.006","article-title":"Acanthamoeba keratitis: an emerging disease gathering importance worldwide?","volume":"29","author":"Lorenzo-Morales","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/EC.00316-07","article-title":"Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference","volume":"7","author":"Lorenzo-Morales","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1099\/jmm.0.2008\/003459-0","article-title":"The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in tenerife, canary islands, Spain","volume":"57","author":"Mart\u00edn-Navarro","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib19","first-page":"2885","article-title":"Effect of steroids on Acanthamoeba cysts and trophozoites","volume":"42","author":"McClellan","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1370-2","article-title":"Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill","volume":"10","author":"Menna-Barreto","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib21","first-page":"229","article-title":"Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis \u2212 an emerging sight-threatening corneal disease in Poland","volume":"64","author":"Padzik","year":"2018","journal-title":"Annals of parasitology"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib24","article-title":"Advocacy for eye health","volume":"20","author":"Prozesky","year":"2007","journal-title":"Community EyE HEaltH Journal"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4103\/0301-4738.100530","article-title":"Advocacy for eye care","volume":"60","author":"Ravilla","year":"2012","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib26","series-title":"Ophthalmic Drugs Contract Manufacturing Industry 2020-2030 by Product, FDF Manufactured, Primary Packaging, Scale of Manufacturing, Company Size, Key Disease Indications, Key Geographical Regions","year":"2020"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamaophthalmol.2016.2627","article-title":"Public attitudes about eye and vision health","volume":"134","author":"Scott","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib28","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/AAC.00686-16","article-title":"The development of drugs against Acanthamoeba infections","volume":"60","author":"Siddiqui","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/AAC.00686-16","article-title":"The development of drugs against Acanthamoeba infections","volume":"60","author":"Siddiqui","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1038\/s41598-018-26914-3","article-title":"Toxic effects of selected proprietary dry eye drops on Acanthamoeba","volume":"8","author":"Sifaoui","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exppara.2017.07.012","article-title":"Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure","volume":"183","author":"Sifaoui","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183795","article-title":"Programmed cell death in Acanthamoeba castellanii neff induced by several molecules present in olive leaf extracts","volume":"12","author":"Sifaoui","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26914-3","article-title":"Toxic effects of selected proprietary dry eye drops on Acanthamoeba","volume":"8","author":"Sifaoui","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exppara.2017.07.012","article-title":"Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure","volume":"183","author":"Sifaoui","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exer.2013.05.021","article-title":"Role of phospholipase A(2) (PLA(2)) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis","volume":"113","author":"Tripathi","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpddr.2021.02.007_bib36","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1099\/mic.0.2007\/008599-0","article-title":"Programmed cell death in entamoeba histolytica induced by the aminoglycoside G418","volume":"153","author":"Villalba","year":"2007","journal-title":"Microbiology (Read.)"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/15376516.2018.1540024","article-title":"Effects of timolol on ca(2+) handling and viability in human prostate cancer cells","volume":"29","author":"Wang","year":"2019","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib38","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1017\/S0031182006000825","article-title":"Programmed cell death in african trypanosomes","volume":"132","author":"Welburn","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2021.02.007_bib39","series-title":"Universal Eye Health: A Global Action Plan 2014-2019","year":"2013"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:50:42Z","timestamp":1761922242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"alternative-id":["S2211320721000105"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.02.007","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro validation of the amoebicidal activity of commercial eye drops as second activity","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}